Rhythm Pharmaceuticals Inc Share Price: RYTM (Rhythm Pharmaceuticals Inc) Stock Price Today & Updates | INDmoney

Question 1

What is Rhythm Pharmaceuticals Inc share price today?

Accepted Answer

Rhythm Pharmaceuticals Inc (RYTM) share price today is {{live_price}}.

Question 2

Can Indians buy Rhythm Pharmaceuticals Inc shares?

Accepted Answer

Yes, Indians can invest in the Rhythm Pharmaceuticals Inc (RYTM) from India.

With INDmoney, you can buy Rhythm Pharmaceuticals Inc at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Rhythm Pharmaceuticals Inc at zero transaction cost.

Question 3

How can I buy Rhythm Pharmaceuticals Inc shares from India?

Accepted Answer

It is very easy to buy Rhythm Pharmaceuticals Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Rhythm Pharmaceuticals Inc be purchased?

Accepted Answer

Yes, you can buy fractional shares of Rhythm Pharmaceuticals Inc with INDmoney app.

Question 5

What are the documents required to start investing in Rhythm Pharmaceuticals Inc stocks?

Accepted Answer

To start investing in Rhythm Pharmaceuticals Inc, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Rhythm Pharmaceuticals Inc

Accepted Answer

Today’s highest price of Rhythm Pharmaceuticals Inc (RYTM) is {{1_rba_end}}.

Today’s lowest price of Rhythm Pharmaceuticals Inc (RYTM) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Rhythm Pharmaceuticals Inc

Accepted Answer

Today's market capitalisation of Rhythm Pharmaceuticals Inc RYTM is 3.0B

Question 8

What is the 52 Week High and Low Range of Rhythm Pharmaceuticals Inc

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Rhythm Pharmaceuticals Inc is down from its 52 Week High?

Accepted Answer

Rhythm Pharmaceuticals Inc (RYTM) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Rhythm Pharmaceuticals Inc is up from its 52 Week low?

Accepted Answer

Rhythm Pharmaceuticals Inc (RYTM) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Rhythm Pharmaceuticals Inc?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Rhythm Pharmaceuticals Inc

Accepted Answer

Dr. David P. Meeker M.D. is the current Chief Executive Officer (CEO) of Rhythm Pharmaceuticals Inc.

Period	Rhythm Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	14.9%	5.7%	0.0%
6 Months	21.15%	6.7%	0.0%
1 Year	127.12%	18.4%	0.0%
3 Years	289.57%	20.8%	-20.2%

Market Capitalization	3.0B
Book Value	$0.64
Earnings Per Share (EPS)	-4.35
Wall Street Target Price	59.3

Profit Margin	-254.89%
Operating Margin TTM	-139.21%

Return On Assets TTM	-47.99%
Return On Equity TTM	-143.42%

Revenue TTM	101.8M
Revenue Per Share TTM	1.71
Quarterly Revenue Growth YOY	51.300000000000004%
Gross Profit TTM	21.5M
EBITDA	-263.9M
Diluted Eps TTM	-4.35
Quarterly Earnings Growth YOY	0.0

Rhythm Pharmaceuticals Inc (RYTM)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Increasing Revenue

Increasing Net Profit

Institutional Holdings

Corporate Announcements

Rhythm Pharmaceuticals Inc Earnings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-4.45
EPS Estimate Next Year	-2.78
EPS Estimate Current Quarter	-0.71
EPS Estimate Next Quarter	-0.77

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Rhythm Pharmaceuticals Inc	3.6%	21.15%	127.12%	289.57%	148.75%
Regeneron Pharmaceuticals, Inc.	-13.97%	8.28%	24.49%	82.67%	258.6%
Novo Nordisk A/s	-14.46%	-7.16%	29.25%	137.43%	348.48%
Alnylam Pharmaceuticals, Inc.	6.47%	77.93%	59.32%	38.21%	249.95%
Vertex Pharmaceuticals Incorporated	-5.23%	12.26%	28.5%	155.67%	163.05%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Rhythm Pharmaceuticals Inc	NA	NA	NA	-4.45	-1.43	-0.48	NA	0.64
Regeneron Pharmaceuticals, Inc.	27.55	27.55	1.42	45.05	0.17	0.08	NA	261.41
Novo Nordisk A/s	38.7	38.7	1.75	3.41	0.89	0.23	0.01	25.24
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-2.49	-15.01	0.02	NA	-0.02
Vertex Pharmaceuticals Incorporated	32.84	NA	0.55	0.32	-0.03	0.13	NA	57.26

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Rhythm Pharmaceuticals Inc	Buy	$3.0B	148.75%	NA	-254.89%
Regeneron Pharmaceuticals, Inc.	Buy	$114.7B	258.6%	27.55	32.04%
Novo Nordisk A/s	Buy	$518.0B	348.48%	38.7	34.84%
Alnylam Pharmaceuticals, Inc.	Buy	$34.9B	249.95%	NA	-3.11%
Vertex Pharmaceuticals Incorporated	Buy	$119.3B	163.05%	32.84	-4.74%

Organization	Rhythm Pharmaceuticals Inc
Employees	226
CEO	Dr. David P. Meeker M.D.
Industry	Health Technology